Section Arrow
Quote
CPHI.NYSE-M
- China Pharma Holdings Inc
Quotes are at least 15-min delayed:2026/05/13 06:47 EDT
Pre Market
Last
 0.8105
-0.0822 (-9.21%)
Bid
0.81
Ask
0.869
High 0.9216 
Low 0.7804 
Volume 35.35K 
Regular Hours (Closed)
Last
 0.8927
+0.35855 (+67.13%)
Day High 
0.95 
Prev. Close
0.53415 
1-M High
0.716 
Volume 
12.77M 
Bid
0.81
Ask
0.869
Day Low
0.3818 
Open
0.396 
1-M Low
0.5 
Market Cap 
21.64M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.54 
20-SMA 0.59 
50-SMA 0.6 
52-W High 2.5977 
52-W Low 0.5 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-0.74/--
Enterprise Value
21.76M
Balance Sheet
Book Value Per Share
0.56
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
4.14M
Operating Revenue Per Share
0.20
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health25.03-4.11-14.10%57.14PE
Pre Market 24.93 -0.1 -0.40%
ZTSZOETIS76.94+0.27+0.35%12.61PE
Pre Market 77.4808 +0.5408 +0.70%
CPHIChina Pharma Holdings Inc0.8927+0.35855+67.13%-- 
Pre Market 0.8105 -0.0822 -9.21%
VTRSViatris17.17+0.25+1.48%-- 
Pre Market 17.18 +0.01 +0.06%
ELANElanco Animal Health21.43-0.29-1.34%-- 
Pre Market 23 +1.57 +7.33%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.